Ampio Pharm - Delisted Pink Sheet

Ampio Pharm is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Ampio Pharm was actively traded.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Ampio Pharm Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Ampio Pharm market risk premium is the additional return an investor will receive from holding Ampio Pharm long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ampio Pharm. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Ampio Pharm's alpha and beta are two of the key measurements used to evaluate Ampio Pharm's performance over the market, the standard measures of volatility play an important role as well.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Ampio Pharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Ampio Pharm Corporate Executives

Elected by the shareholders, the Ampio Pharm's board of directors comprises two types of representatives: Ampio Pharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ampio. The board's role is to monitor Ampio Pharm's management team and ensure that shareholders' interests are well served. Ampio Pharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ampio Pharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
Daniel StokelyCFO, Corporate SecretaryProfile
Daniel CPACorporate CFOProfile
Thomas ChilcottInterim CFOProfile
Gregory GouldCFO, Treasurer, Corporate SecretaryProfile
Holli CherevkaCOOProfile

Still Interested in Ampio Pharm?

Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in Ampio Pink Sheet

If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences